Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib and Lapatinib in HER2+ Advanced Breast Cancer
NCT00347919Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2006
- Primary completion
- Aug 2008
- Countries
- 16
01
Overview
A Phase 2 trial of pazopanib in breast cancer, sponsored by GSK. Started Jul 2006; status: completed.
02
Drugs
pazopanib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00347919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347919.